Life Science REIT Statistics

Total Valuation

Life Science REIT has a market cap or net worth of GBP 135.10 million. The enterprise value is 239.64 million.

Market Cap	135.10M
Enterprise Value	239.64M

Important Dates

The last earnings date was Thursday, September 26, 2024.

Earnings Date	Sep 26, 2024
Ex-Dividend Date	Oct 3, 2024

Share Statistics

Life Science REIT has 350.00 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	350.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	0.03%
Owned by Institutions (%)	90.18%
Float	326.77M

Valuation Ratios

Price/FFO Ratio	n/a
Price/AFFO Ratio	n/a
PE Ratio	n/a
Forward PE	25.51
PS Ratio	6.71
PB Ratio	0.51
P/TBV Ratio	0.51
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	2.55

Financial Ratio History

Enterprise Valuation

EV / Earnings	-5.98
EV / Sales	11.91
EV / EBITDA	n/a
EV / EBIT	25.41
EV / FCF	-13.21

Financial Position

The company has a current ratio of 1.20, with a Debt / Equity ratio of 0.44.

Current Ratio	1.20
Quick Ratio	1.15
Debt / Equity	0.44
Debt / EBITDA	n/a
Debt / FCF	-6.51
Interest Coverage	0.92

Financial Efficiency

Return on equity (ROE) is -13.77% and return on invested capital (ROIC) is 1.47%.

Return on Equity (ROE)	-13.77%
Return on Assets (ROA)	1.40%
Return on Capital (ROIC)	1.47%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.05
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -37.38% in the last 52 weeks. The beta is 0.09, so Life Science REIT's price volatility has been lower than the market average.

Beta (5Y)	0.09
52-Week Price Change	-37.38%
50-Day Moving Average	39.65
200-Day Moving Average	36.99
Relative Strength Index (RSI)	47.33
Average Volume (20 Days)	698,187

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Life Science REIT had revenue of GBP 20.12 million and -40.04 million in losses. Loss per share was -0.11.

Revenue	20.12M
Gross Profit	14.51M
Operating Income	9.43M
Pretax Income	-40.29M
Net Income	-40.04M
EBITDA	n/a
EBIT	9.43M
Loss Per Share	-0.11

Full Income Statement

Balance Sheet

The company has 13.53 million in cash and 118.07 million in debt, giving a net cash position of -104.54 million or -0.30 per share.

Cash & Cash Equivalents	13.53M
Total Debt	118.07M
Net Cash	-104.54M
Net Cash Per Share	-0.30
Equity (Book Value)	267.23M
Book Value Per Share	0.76
Working Capital	2.66M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 11.78 million and capital expenditures -29.92 million, giving a free cash flow of -18.15 million.

Operating Cash Flow	11.78M
Capital Expenditures	-29.92M
Free Cash Flow	-18.15M
FCF Per Share	-0.05

Full Cash Flow Statement

Margins

Gross margin is 72.13%, with operating and profit margins of 46.87% and -198.99%.

Gross Margin	72.13%
Operating Margin	46.87%
Pretax Margin	-200.20%
Profit Margin	-198.99%
EBITDA Margin	n/a
EBIT Margin	46.87%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 5.18%.

Dividend Per Share	0.02
Dividend Yield	5.18%
Dividend Growth (YoY)	-50.00%
Years of Dividend Growth	2
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	5.18%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a